Injectable GLP-1 Weight Loss Treatment
Injectable GLP-1 medications are prescription treatments that support weight loss by helping to regulate appetite and reduce calorie intake. They mimic naturally occurring hormones involved in controlling hunger, helping you feel fuller for longer, reduce cravings, and make it easier to maintain healthier eating habits when combined with a balanced diet and regular physical activity.
Wegovy
Wegovy (semaglutide) is a once-weekly injection that works by mimicking the GLP-1 hormone, helping to reduce appetite, increase feelings of fullness, and slow the rate at which food leaves the stomach. Treatment begins at a low dose and is gradually increased over several weeks to help minimise side effects, such as nausea or stomach discomfort. Clinical studies have shown that, alongside healthy lifestyle changes, Wegovy can help many people achieve significant and sustained weight loss.
Mounjaro
Mounjaro (tirzepatide) is a once-weekly injectable treatment that activates both the GLP-1 and GIP receptors, helping to regulate appetite, improve feelings of fullness, and reduce food intake. By targeting two natural hormone pathways involved in blood sugar and appetite regulation, Mounjaro has demonstrated significant weight loss in clinical studies when used alongside a healthy diet and increased physical activity. As with Wegovy, treatment starts at a lower dose and is gradually increased to improve tolerability.
Orlistat
Orlistat is an oral weight loss medication that works differently from injectable treatments. Instead of reducing appetite, it blocks the absorption of some of the fat consumed in your diet, allowing it to pass naturally through the body. Orlistat is most effective when combined with a reduced-calorie, lower-fat diet and regular exercise. It may be a suitable option for individuals who prefer a tablet rather than a weekly injection.